Medicine & Life Sciences
Neoplasms
100%
Pancreatic Neoplasms
82%
Pharmacokinetics
43%
DNA Damage
38%
Proteins
38%
Apoptosis
38%
Ovarian Neoplasms
37%
Survival
36%
Therapeutics
33%
Adenocarcinoma
33%
Drug Therapy
32%
Poly(ADP-ribose) Polymerase Inhibitors
30%
Renal Cell Carcinoma
28%
Mutation
28%
Topotecan
24%
Phosphorylation
24%
Genes
23%
gemcitabine
23%
Breast Neoplasms
22%
Acute Myeloid Leukemia
22%
Cell Line
21%
Irinotecan
21%
Growth
21%
Melanoma
20%
Carcinogenesis
20%
DNA
19%
Heterografts
19%
Transcription Factors
19%
T-Lymphocytes
19%
Type I DNA Topoisomerase
19%
Phosphotransferases
18%
Neoplasm Metastasis
18%
Maximum Tolerated Dose
18%
Carcinoma
18%
Homologous Recombination
18%
Glycogen Synthase Kinase 3
18%
Leukemia
18%
DNA Repair
18%
Actins
17%
Pharmaceutical Preparations
16%
Cisplatin
15%
Carboplatin
15%
Natural Killer Cells
15%
In Vitro Techniques
15%
Ligands
15%
Child
14%
Paclitaxel
14%
Nephrectomy
14%
Platinum
14%
Temozolomide
14%
veliparib
14%
tipifarnib
14%
Etoposide
13%
Glioma
13%
Cell Death
13%
Progression-Free Survival
13%
Caspases
13%
Chromatin
12%
Epigenomics
12%
Clinical Trials
12%
Checkpoint Kinase 1
12%
Type II DNA Topoisomerase
12%
Poly(ADP-ribose) Polymerases
11%
alvocidib
11%
4-hydroxy-N-desmethyltamoxifen
11%
Glioblastoma
11%
Non-Small Cell Lung Carcinoma
11%
pembrolizumab
11%
Gene Expression
11%
Pancreatic Diseases
11%
Antineoplastic Agents
11%
Appointments and Schedules
11%
Immunotherapy
11%
Camptothecin
11%
Tyrosine
10%
rucaparib
10%
Peptides
10%
Cytarabine
10%
Farnesyltranstransferase
10%
Cholangiocarcinoma
10%
Double-Stranded DNA Breaks
10%
Endosomes
10%
Wiskott-Aldrich Syndrome Protein
10%
Interviews
10%
Confidence Intervals
10%
Up-Regulation
10%
tanespimycin
9%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9%
Down-Regulation
9%
Enzymes
9%
Radiotherapy
9%
Pediatrics
9%
Recurrence
9%
Genomic Instability
9%
Cell Proliferation
9%
ErbB Receptors
9%
Biomarkers
9%
Protein-Tyrosine Kinases
8%
NSC 680410
8%